Pfizer Inc (PFE) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 28 2026 to Jun 29 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Pfizer Inc  (NYSE: PFE)


Pfizer Inc's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Pfizer Inc's ROA in the second quarter of 2026?
Pfizer Inc achieved a return on average assets (ROA) of 2.08 % in its second quarter of 2026, which is below Pfizer Inc's average return on assets, which stands at 7.66%.

ROA decreased relative to the period ending Mar 29 2026, due to the decline in net income.

However, within the Healthcare sector 186 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 28 2026 quarter, so far to 1459, from total ROA ranking in the first quarter of 2026 at 1679.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 28 2026)
II. Quarter		 (Mar 29 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 28 2025)
III. Quarter		 (Jun 29 2025)
II. Quarter
Y / Y Total Assets Change -1.14 % 0.58 % -2.58 % -4.9 % -4.67 %
Y / Y Net Income Change - -9.32 % - -20.63 % 6000 %
Net Income (TTM) in million 4,370 7,535 7,812 9,869 10,792
Return On Assets (TTM) 2.08 % 3.57 % 3.71 % 4.65 % 5.03 %
PFE's Total Ranking # 1459 # 1679 # 1237 # 1163 # 1427
Total Assets (TTM) in million 203,745 209,244 219,639 208,731 206,095
Seq. Total Assets Change -2.63 % -4.73 % 5.23 % 1.28 % -0.93 %
Seq. Net Income Change - - - 21.24 % -1.51 %

PFE's 5 Years Annual ROA >> Back to PFE Management Effectiveness >> Compare PFE ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 67
Sector # 187
Overall # 1789

Return On Assets Statistics
High Average Low
17.44 %
7.66 %
-1.17 %
(Dec. 30. 2006)   (Jun 30 2024)





Financial Statements
Pfizer Inc's Assets $ 203,745 million PFE's Balance sheet
Pfizer Inc's Income $ -237 million Quarterly PFE's Income Statement
PFE's Income by Division See PFE's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change -1.69 % -5.79 % 14.86 % 8.67 % 17.67 %
Total Assets in million 209,781 213,396 226,501 197,205 181,476
Y / Y Net Income Change -3.1 % 273.59 % -93.13 % 42.6 % 128.19 %
Net Income in million 7,812 8,062 2,158 31,407 22,025
Annual Return On Assets 3.72 % 3.78 % 0.95 % 15.93 % 12.14 %

PFE's 5 Years Annual ROA >> Back to PFE Management Effectiveness >> Compare PFE ROA to its Competitors



Comment on PFE's ROA in the fiscal year ending 2025
In the fiscal year 2025 Pfizer Inc's ROA decreased compared to previous year to 3.72 %, due to deterioration of net income -3.1 % to $7,812.00 million, from $8,062.00 million a year ago, as PFE's assets were $209,781.00 million.


More Return On Assets Ratios
PFE's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PFE's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PFE's Competitors
Subscribers only: Roa for Pfizer Inc's Suppliers
Subscribers only: Return On Assets for PFE's Customers

You may also want to know
PFE's Roi PFE's Inventory Turnover Ratio PFE's Growth Rates PFE's Dividend Comparisons
PFE's Profitability Ratios PFE's Asset Turnover Ratio PFE's Dividend Growth
PFE's Roe PFE's Valuation Ratios PFE's Financial Strength Ratios PFE's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 28 2026, within Healthcare Sector ROA
Medtronic Plc  5.71 %
Labcorp Holdings Inc   5.40 %
Merit Medical Systems Inc  5.34 %
Sotera Health Company  5.03 %
Vericel Corporation  5.02 %
Kewaunee Scientific Corporation  4.96 %
Pacs Group Inc   4.78 %
Amphastar Pharmaceuticals Inc   4.70 %
Abbvie Inc   4.68 %
The Cooper Companies Inc   4.57 %
IMPACT BIOMEDICAL INC.  4.47 %
Nrc Health  4.31 %
Cadre Holdings inc   4.29 %
The Pennant Group Inc   4.14 %
U S Physical Therapy Inc  4.08 %
Haemonetics Corporation  3.99 %
Henry Schein Inc   3.79 %
Integer Holdings Corporation  3.76 %
Zimmer Biomet Holdings Inc   3.51 %
Ardent Health Inc   3.22 %
Community Health Systems Inc   3.17 %
Vaso Corporation  2.92 %
Collegium Pharmaceutical Inc   2.72 %
National Vision Holdings Inc   2.53 %
Conmed Corporation  2.44 %
Merck and Co Inc   2.42 %
Privia Health Group Inc   2.41 %
Lifestance Health Group Inc   2.33 %
Bio rad Laboratories Inc   2.21 %
Pfizer Inc  2.12 %

Date modified: 2026-09-12T06:19:22+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.